APPLYING ARTIFICIAL INTELLIGENCE TO MEDICAL IMAGING FOR CARDIOVASCULAR DISEASE DETECTION
Parmida Ghorbanian, PhD Candidate,
University of Western Australia & Advanced Clinical and Translational Cardiovascular Imaging,
Harry Perkins Institute of Medical Research,
Western Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | July 2026
Parmida is a software engineer and biomedical scientist whose research focuses on translating novel medical imaging technologies into clinical practice to improve the diagnosis and management of cardiovascular disease.
Her current work applies advanced deep learning techniques to retinal polarization-sensitive optical coherence tomography (PS-OCT) imaging, aiming to generate clinically meaningful biomarkers and predictions of cardiovascular disease. Parmida’s collaboration partners include Fiona Stanley Hospital in Murdoch, Western Australia.
She is the recipient of the Novel Heart Disease Imaging Through AI HDR Scholarship and has received multiple awards for her research, including the WACRA Heart-to-Vessel Showcase Award, the South Metropolitan Health Service 3-Minute Project Competition, and the Data Institute Postgraduate Student Researcher Pitch Winner award.
Most recently, she was selected as a finalist in the INCITE Awards, Western Australia’s premier technology innovation awards program.
Source: Supplied and adapted
-
Next-generation NK cell-based immunotherapies for hard-to-treat cancers
Associate Professor Fernando Guimaraes is an internationally recognised leader in cancer immunotherapy and natural killer (NK) cell biology. Based at The University of Queensland, he leads innovative research focused on developing next-generation NK cell-based immunotherapies for hard-to-treat cancers, including sarcomas and neuroblastoma.
-
Development of novel analytical and diagnostic tools using nanotechnology and microfluidics
Dr Alain Wuethrich is an NHMRC Emerging Leader fellow and ARC DECRA awardee at the Australian Institute for Bioengineering and Nanotechnology.
Hailing from Switzerland, research focuses on the development of novel analytical and diagnostic tools that harness nanotechnology and microfluidics; two rapidly growing fields with high potential to provide diagnostic solutions needed for precision medicine.
-
Trials in treating STIs, vaccines and lipid lowering medications
Since joining Paratus Clinical Research in 2022, Dr Pi Lip Seet has served as both Principal Investigator and Sub-Investigator across Phase I–IV industry-sponsored clinical trials. His research experience spans vaccines, immunology, cardiovascular and endocrine disease, respiratory medicine, gastroenterology, pain management, sleep medicine and adult psychiatry. He has been involved in multiple vaccine development programs, including RSV, influenza, COVID-19, herpes zoster and pneumococcal studies.
